Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Daprodustat in Period 1	0	7
Total, all-cause mortality	rhEPO in Period 1	0	7
Total, all-cause mortality	rhEPO in Period 2	0	7
Total, all-cause mortality	Daprodustat in Period 2	0	7
Total, other adverse events	Daprodustat in Period 1	3	7
Total, other adverse events	rhEPO in Period 1	3	7
Total, other adverse events	rhEPO in Period 2	2	7
Total, other adverse events	Daprodustat in Period 2	3	7
Total, serious adverse events	Daprodustat in Period 1	0	7
Total, serious adverse events	rhEPO in Period 1	1	7
Total, serious adverse events	rhEPO in Period 2	0	7
Total, serious adverse events	Daprodustat in Period 2	1	7

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03457701/event-totals